Makes it easy to quickly get an idea of what was debated and decided in washington. Scroll through and spend a few minutes on cspans points of interest. Natalie fertig covers a one and cannabis industry for political and join dystopias whom your natalie fertig, good morning. Guest good morning. Host thanks or joining us. Tell us about this recent s we can tell us why it happened. Guest so the Biden Administration specifically the Department Health and Human Services issued a letter that outlines the recommendation for the schedule that cannabis should be on. Cannabis is to a schedule one drug on the controlled substance act which means its in the same categoryis as heroin and is been there since 19 said when the bill was signed into law by president nixon. Obviously americans relationship with cannabis has changed dramatically since 1970. We now have half the country lives and as they were cannabis is legal for recreation use and the vast majority of americans live in a state where it is legal for medical use. So last october right before the midterm election, President Biden issued executive order, one of the portions of that executive order asked hhs to review all of the Available Research on cannabis and say whether they thought it should be moved to a different schedule. There are five schedulessc now. Its at the most extreme which is theres no medical use for it. They have now completed the review and thats the big deal about this letter is at 11 months later they have completed this review. They have said, you know, we want it toou be schedule three, which means it would be taken out of the more strict part of the csa, of the controlled substances act. That is not binding though. That letter was sent to the dea which has final review and can make the final decision of whether or not cannabis would actually be moved to a different schedule. Thats thea next step and honestly dont know how long it would take. I wish i knew d of anyone at the dea is watching the love to have a here to talk. Need i could come back and give you more info on that drama it was hhs secretary su not a treat after they made the announcement a part of that saying i cannot share that following the date and science hhs has responded to that directive. Talk about the data sites. What researchers sites went into making this recommendation . Guest hhs had eightpoint process, a different categories of scientific research. And theyre looking for both the potential for abuse of a drug and also looking for current medical use. Medical uses which seem to have good, theres a good framework there for more research to be done into those uses. We scheduled a press schedule three is going to make it way, way easier to study. Right now its very difficult pick you up to get a and Research License as scientists. You can only use cannabis has been called byus someone who has schedule and Research License a group cannabis. And thats really slow down our knowledge as americans about cannabis and both its pros and its cons. Host when it comes been, if this reclassification happens, who does it benefit most . I suspect its the industry that would benefit from this kind of move . Guest very happy about this idea, primarily because it will reduce the tax burden they currently have. Theres a code called tax code to a de that was originally made so that people who were trafficking in narcotics could not write the business expenses off 280e dash up with a miso is cannabis businesses that are legal at the state level cannot write their businesses off. So if they buy pens pins oy buy tables for their dispensary speeded we will break away from this discussion to keep our over 40year commitment to covering congress. You can watch all of our washington journal segments if you go to our website cspan. Org. Today the u. S. Senate is back in session following its summer recess. Sandage will be voted on the Federal Reserve vice chair nomination later this afternoon. And i like to the of the u. S. Senate here on cspan2. And now live to the floor of the u. S. Senate here on cspan2